WEKO3
アイテム
{"_buckets": {"deposit": "c5bc0387-6970-4c84-bb3e-e810c8ff610b"}, "_deposit": {"created_by": 1, "id": "64917", "owners": [1], "pid": {"revision_id": 0, "type": "depid", "value": "64917"}, "status": "published"}, "_oai": {"id": "oai:repo.qst.go.jp:00064917", "sets": ["29"]}, "author_link": ["639762", "639766", "639761", "639765", "639759", "639764", "639763", "639768", "639760", "639767", "639769"], "item_10005_date_7": {"attribute_name": "発表年月日", "attribute_value_mlt": [{"subitem_date_issued_datetime": "2012-11-25", "subitem_date_issued_type": "Issued"}]}, "item_10005_description_5": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "(Purpose)\nTo evaluate the toxicity and efficacy of radiotherapy concurrently with weekly cisplatin follow-ed by adjuvant chemotherapy for N2-3 nasopharyngeal cancer.\n\\n(Materials and Methods)\nBetween 2005 and 2009, 121 patients with nasopharyngeal cancer (T1-4 N2-3 M0) were registered from Viet Nam, Malaysia, Indonesia, Thailand, The Philippines, China and Bangladesh. Patients were treated with 2-dimensional radiotherapy concurrently with weekly cisplatin (30mg/m2) followed by adjvant chemotherapy consisting of cisplatin (80mg/m2 on Day 1) and fluorouracil (800mg/m2 on Days 1_5) for three cycles.\n\\n(Results)\nNinety-three percent of the patients completed at least 4 cycles of weekly cisplatin during radiotherapy, and 82% completed at least 2 cycles of adjvant chemotherapy. Complete response was obtained in 95% of the patients. With a median follow-up time of 46 months for the survival, and overall survival rated were 75%, 65%, and 52%, respectively. No treatment-related deaths occurred. Grade 3-4 toxicities of mucositis, nausea/vomiing, and leukopenia were observed in 34% , 4%, and 4% of the patients, respectively.\n\\n(Conclusion)\nThe current results showed that concurrent chemoradiotherapy followed by adjuvant chemotherapy of our regimen was safe and effective in the participating institutes.", "subitem_description_type": "Abstract"}]}, "item_10005_description_6": {"attribute_name": "会議概要(会議名, 開催地, 会期, 主催者等)", "attribute_value_mlt": [{"subitem_description": "日本放射線腫瘍学会第25回学術大会", "subitem_description_type": "Other"}]}, "item_access_right": {"attribute_name": "アクセス権", "attribute_value_mlt": [{"subitem_access_right": "metadata only access", "subitem_access_right_uri": "http://purl.org/coar/access_right/c_14cb"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "大野, 達也"}], "nameIdentifiers": [{"nameIdentifier": "639759", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "加藤, 真吾"}], "nameIdentifiers": [{"nameIdentifier": "639760", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "若月, 優"}], "nameIdentifiers": [{"nameIdentifier": "639761", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "唐澤, 久美子"}], "nameIdentifiers": [{"nameIdentifier": "639762", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "中野, 隆史"}], "nameIdentifiers": [{"nameIdentifier": "639763", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻井, 博彦"}], "nameIdentifiers": [{"nameIdentifier": "639764", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "大野 達也", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "639765", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "加藤 眞吾", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "639766", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "若月 優", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "639767", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "唐澤 久美子", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "639768", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "辻井 博彦", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "639769", "nameIdentifierScheme": "WEKO"}]}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "jpn"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "conference object", "resourceuri": "http://purl.org/coar/resource_type/c_c94f"}]}, "item_title": "Radiotherapy concurrently with weekly cisplatin followed by adjuvant chemotherapy for N2-3 nasopharyngeal cancer: Multicenter trial of the Forum for Nuclear Cooperation in Asia (FNCA)", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "Radiotherapy concurrently with weekly cisplatin followed by adjuvant chemotherapy for N2-3 nasopharyngeal cancer: Multicenter trial of the Forum for Nuclear Cooperation in Asia (FNCA)"}]}, "item_type_id": "10005", "owner": "1", "path": ["29"], "permalink_uri": "https://repo.qst.go.jp/records/64917", "pubdate": {"attribute_name": "公開日", "attribute_value": "2013-02-12"}, "publish_date": "2013-02-12", "publish_status": "0", "recid": "64917", "relation": {}, "relation_version_is_last": true, "title": ["Radiotherapy concurrently with weekly cisplatin followed by adjuvant chemotherapy for N2-3 nasopharyngeal cancer: Multicenter trial of the Forum for Nuclear Cooperation in Asia (FNCA)"], "weko_shared_id": -1}
Radiotherapy concurrently with weekly cisplatin followed by adjuvant chemotherapy for N2-3 nasopharyngeal cancer: Multicenter trial of the Forum for Nuclear Cooperation in Asia (FNCA)
https://repo.qst.go.jp/records/64917
https://repo.qst.go.jp/records/649174317a1a6-f8f5-47ed-bc07-214e200f6820
Item type | 会議発表用資料 / Presentation(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2013-02-12 | |||||
タイトル | ||||||
タイトル | Radiotherapy concurrently with weekly cisplatin followed by adjuvant chemotherapy for N2-3 nasopharyngeal cancer: Multicenter trial of the Forum for Nuclear Cooperation in Asia (FNCA) | |||||
言語 | ||||||
言語 | jpn | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_c94f | |||||
資源タイプ | conference object | |||||
アクセス権 | ||||||
アクセス権 | metadata only access | |||||
アクセス権URI | http://purl.org/coar/access_right/c_14cb | |||||
著者 |
大野, 達也
× 大野, 達也× 加藤, 真吾× 若月, 優× 唐澤, 久美子× 中野, 隆史× 辻井, 博彦× 大野 達也× 加藤 眞吾× 若月 優× 唐澤 久美子× 辻井 博彦 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | (Purpose) To evaluate the toxicity and efficacy of radiotherapy concurrently with weekly cisplatin follow-ed by adjuvant chemotherapy for N2-3 nasopharyngeal cancer. \n(Materials and Methods) Between 2005 and 2009, 121 patients with nasopharyngeal cancer (T1-4 N2-3 M0) were registered from Viet Nam, Malaysia, Indonesia, Thailand, The Philippines, China and Bangladesh. Patients were treated with 2-dimensional radiotherapy concurrently with weekly cisplatin (30mg/m2) followed by adjvant chemotherapy consisting of cisplatin (80mg/m2 on Day 1) and fluorouracil (800mg/m2 on Days 1_5) for three cycles. \n(Results) Ninety-three percent of the patients completed at least 4 cycles of weekly cisplatin during radiotherapy, and 82% completed at least 2 cycles of adjvant chemotherapy. Complete response was obtained in 95% of the patients. With a median follow-up time of 46 months for the survival, and overall survival rated were 75%, 65%, and 52%, respectively. No treatment-related deaths occurred. Grade 3-4 toxicities of mucositis, nausea/vomiing, and leukopenia were observed in 34% , 4%, and 4% of the patients, respectively. \n(Conclusion) The current results showed that concurrent chemoradiotherapy followed by adjuvant chemotherapy of our regimen was safe and effective in the participating institutes. |
|||||
会議概要(会議名, 開催地, 会期, 主催者等) | ||||||
内容記述タイプ | Other | |||||
内容記述 | 日本放射線腫瘍学会第25回学術大会 | |||||
発表年月日 | ||||||
日付 | 2012-11-25 | |||||
日付タイプ | Issued |